Inrebic (fedratinib) - BMS
Xospata (gilteritinib) - Astellas
Vanflyta (quizartinib) - Daiichi Sankyo
Jakafi oral (ruxolitinib) - Novartis, Incyte
momelotinib (CYT 387) - Sierra Oncology
crenolanib besylate (ARO-002) - AROG
https://eventpilot.us/web/page.php?page=Session&project=ASH21&id=148822
 
Mohammad Azhar1; Zachary Kincaid, BS2; Meenu Kesarwani, PhD3; Mark Wunderlich, MS4; Tahir Latif, MD5,6; Daniel Starczynowski, PhD1; Mohammad Azam, PhD7
 
Nov 5, 2021
 
Prev Next